277 related articles for article (PubMed ID: 18420192)
1. Sphingolipid signalling in the cardiovascular system: good, bad or both?
Alewijnse AE; Peters SL
Eur J Pharmacol; 2008 May; 585(2-3):292-302. PubMed ID: 18420192
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipid metabolites in neural signalling and function.
Colombaioni L; Garcia-Gil M
Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
[TBL] [Abstract][Full Text] [Related]
3. [Sphingolipids and their medical impact].
Sensken SC; Gräler MH
Dtsch Med Wochenschr; 2009 Feb; 134(6):259-63. PubMed ID: 19180419
[TBL] [Abstract][Full Text] [Related]
4. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids: players in the pathology of metabolic disease.
Cowart LA
Trends Endocrinol Metab; 2009 Jan; 20(1):34-42. PubMed ID: 19008117
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids in infectious diseases.
Hanada K
Jpn J Infect Dis; 2005 Jun; 58(3):131-48. PubMed ID: 15973004
[TBL] [Abstract][Full Text] [Related]
7. Beyond a structural component: sphingolipids in immunology.
Prieschl EE; Baumruker T
Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology.
Perrotta C; De Palma C; Clementi E
Biol Chem; 2008 Nov; 389(11):1391-7. PubMed ID: 18783333
[TBL] [Abstract][Full Text] [Related]
9. Chemical tools to investigate sphingolipid metabolism and functions.
Delgado A; Casas J; Llebaria A; Abad JL; Fabriás G
ChemMedChem; 2007 May; 2(5):580-606. PubMed ID: 17252619
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system.
Okada T; Kajimoto T; Jahangeer S; Nakamura S
Cell Signal; 2009 Jan; 21(1):7-13. PubMed ID: 18694820
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipid signalling and liver diseases.
Marí M; Fernández-Checa JC
Liver Int; 2007 May; 27(4):440-50. PubMed ID: 17403183
[TBL] [Abstract][Full Text] [Related]
12. [Sphingolipid and apoptosis].
Wang J; Hu XS; Shi JP
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
[TBL] [Abstract][Full Text] [Related]
13. The multi-functional role of sphingosylphosphorylcholine.
Nixon GF; Mathieson FA; Hunter I
Prog Lipid Res; 2008 Jan; 47(1):62-75. PubMed ID: 18042469
[TBL] [Abstract][Full Text] [Related]
14. Signalling functions for sphingolipid long-chain bases in Saccharomyces cerevisiae.
Liu K; Zhang X; Sumanasekera C; Lester RL; Dickson RC
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1170-3. PubMed ID: 16246074
[TBL] [Abstract][Full Text] [Related]
15. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease.
van der Giet M; Tölle M; Kleuser B
Biol Chem; 2008 Nov; 389(11):1381-90. PubMed ID: 18925828
[TBL] [Abstract][Full Text] [Related]
16. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
17. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation.
Cerbon J; Olguin T; Alvarez-Grave PR; López-Sánchez RC
Exp Parasitol; 2009 Jun; 122(2):106-11. PubMed ID: 19249300
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipids and the regulation of the immune response.
Baumruker T; Prieschl EE
Semin Immunol; 2002 Feb; 14(1):57-63. PubMed ID: 11884231
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid metabolizing enzymes as novel therapeutic targets.
Billich A; Baumruker T
Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
[TBL] [Abstract][Full Text] [Related]
20. Brave little yeast, please guide us to thebes: sphingolipid function in S. cerevisiae.
Schneiter R
Bioessays; 1999 Dec; 21(12):1004-10. PubMed ID: 10580985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]